Healy James

DirectorBioAge Labs, Inc. (BIOA) · full profile →Form 4 · filed Sep 27, 2024
Net Buying
Open-Market Buys
$12.0M
Open-Market Sells
$0
Net Open-Market Flow
$12.0M
Transactions
8
6 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 27, 2024Conversion(C)1.6M1.6M
Sep 27, 2024Buy(P)589K$18.00$10.6M2.2M
Sep 27, 2024Buy(P)26K$18.00$477K26K
Sep 27, 2024Buy(P)18K$18.00$330K18K
Sep 27, 2024Buy(P)22K$18.00$393K22K
Sep 27, 2024Buy(P)11K$18.00$200K11K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 27, 2024Conversion(C)7.3M0
Sep 25, 2024Grant(A)15K$015K

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-024044) within minutes of acceptance. Every field above traces to the original document. Verify it directly: